[Synthesis and uterotrophic effect of new delayed-action estrogens of the type 17 alpha substituted derivatives of estradiol-3-methyl ether].
D000284:Administration, Oral; D000818:Animals; D003692:Delayed-Action Preparations; D004353:Drug Evaluation, Preclinical; D004958:Estradiol / Q000008:administration & dosage / Q000138:chemical synthesis* / Q000494:pharmacology; D005260:Female; D008738:Methyl Ethers / Q000008:administration & dosage / Q000138:chemical synthesis / Q000494:pharmacology; D051379:Mice; D014599:Uterus / Q000187:drug effects*
D003692:Delayed-Action Preparations; D008738:Methyl Ethers; D004958:Estradiol
Synthese und uterotrope Wirkung neuartiger gebremster Ostrogene vom Typ 17 alpha-substituierter Derivate des Ostradiol-3-methyläthers